bioRxivCancer BiologyPreprint
Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of oesophageal cancer
P. Ganguli, C. Colomina-Basanta, A. Acha-Sagrado, H. Misetic, M. Armero-Pineiro, A. Mendez, A. Zahra, G. Devonshire, G. Kelly, A. Freeman, M. Green, E. Nye, A. Bichisecchi, P. Bonfanti, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, M. Rodriguez-Justo, J. Spencer, R. C. Fitzgerald, F. D. Ciccarelli
Abstract
CDKN2A is a tumour suppressor located in chromosome 9p21 and frequently lost in Barretts oesophagus (BO) and oesophageal adenocarcinoma (OAC). How CDKN2A and other 9p21 gene co-deletions affect OAC evolution remains understudied. We explored the effects of 9p21 loss in OACs and cancer progressor and non-progressor BOs with matched genomic, transcriptomic, and clinical data. Despite its cancer driver role, CDKN2A loss in BO prevents OAC initiation by counter-selecting subsequent TP53 alterations. 9p21 gene co-deletions predict poor patient survival in OAC but not BO through context-dependent effects on cell cycle, oxidative phosphorylation, and interferon response. Immune quantifications using bulk transcriptome, RNAscope and high-dimensional tissue imaging showed that IFNE loss reduces immune infiltration in BO but not OAC. Mechanistically, CDKN2A loss suppresses the maintenance of squamous epithelium, contributing to a more aggressive phenotype. Our study demonstrates context-dependent roles of cancer genes during disease evolution, with consequences for cancer detection and patient management.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to Oesophageal Adenocarcinoma
C. Rogerson, S. Ogden, … A. D. Sharrocks·bioRxiv·Feb 10, 2020
- Extrachromosomal DNA in the cancerous transformation of Barrett's esophagus
Jens Luebeck, Alvin Wei Tian Ng, … Paul S. Mischel·bioRxiv·Jul 25, 2022
- Single-cell Genomic Copy Number Evolution Reveals Frequent Loss of the Y chromosome in Esophageal Adenocarcinoma
Shiwei Yin, Na Zhong, … Jun Xia·bioRxiv·Sep 14, 2025
- Identification of a primitive intestinal transcription factor network shared between oesophageal adenocarcinoma and its pre-cancerous precursor state
C. Rogerson, E. Britton, … A. D. Sharrocks·bioRxiv·Jul 30, 2018
- Genomic copy number predicts oesophageal cancer years before transformation
Sarah Killcoyne, Eleanor Gregson, … Rebecca Claire Fitzgerald·Nature MedicinePeer-reviewed·Sep 7, 2020
- The EphB2-MYC Axis is a Major Determinant of Barrett's Pathobiology and a Therapeutic Vulnerability in Esophageal Cancer
S. Venkitachalam, D. Babu, … K. Guda·bioRxiv·May 13, 2021